ロード中...
A highly specific SpCas9 variant is identified by in vivo screening in yeast
Despite the utility of CRISPR-Cas9 nucleases for genome editing, the potential for off-target activity limits their application, especially for therapeutic purposes1,2. We developed a yeast-based assay to identify optimized Streptococcus pyogenes Cas9 (SpCas9) variants that enables simultaneous eval...
保存先:
| 出版年: | Nat Biotechnol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6066108/ https://ncbi.nlm.nih.gov/pubmed/29431739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4066 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|